Camlin Fine Sciences Limited has informed the Exchange about Update on Acquisition of Vinpai S..A.
CAMLINFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 2.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Camlin Fine Sciences is updating the stock exchanges on its earlier announced plan to acquire a majority stake in Vinpai S.A., a foreign company. The deal, originally expected to close by September 30, 2025, has had its completion timeline extended to November 30, 2025 by mutual agreement between the parties. The delay was caused because the Sellers (foreign founders of Vinpai) needed to obtain a Permanent Account Number (PAN) to enable a share swap, which has now been secured. The acquisition will be funded through a preferential allotment of Camlin Fine Sciences equity shares to the Sellers, and the company will shortly seek Board and Shareholder approval for this share issuance.
The two-month delay in completing the acquisition is procedural rather than fundamental, as the key hurdle (PAN for foreign Sellers) has been resolved. Shareholders should expect a Board/EGM approval request for the preferential share issuance in the coming weeks. Successful completion will expand Camlin Fine Sciences' international footprint through Vinpai, though it will also dilute existing shareholders' equity due to the share-swap structure.